Michael Madaio to Feasibility Studies
This is a "connection" page, showing publications Michael Madaio has written about Feasibility Studies.
Connection Strength
0.091
-
A human monoclonal antibody against the collagen type IV a3NC1 domain is a non-invasive optical biomarker for glomerular diseases. Kidney Int. 2013 Aug; 84(2):403-8.
Score: 0.091